David Bassett is a partner in the firm's Litigation/Controversy Department, a member of the Intellectual Property Litigation Practice Group and FinTech Group, and is the chair of the firm's Associates Committee. He joined the firm in 1989.
Mr. Bassett's practice concentrates on intellectual property litigation, particularly on biotechnology patent disputes. He also represents clients in a wide variety of other business disputes, including breach of contract, Lanham Act and Internet-related claims. Mr. Bassett's intellectual property litigation clients have included Biogen, Dynatech, Procter & Gamble, Raytheon, Genetics Institute, Calgene, Cephalon, Kurzweil Music, RSA Security, Transkaryotic Therapies, Braintree Laboratories and many others. His practice has covered all facets of litigation, including discovery, settlement, alternative dispute resolution, trials and appeals. He has appeared before the Courts of Appeals for the First and Federal Circuits.